These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 7907791

  • 41. In vivo microdialysis studies on somatodendritic dopamine release in the rat substantia nigra: effects of unilateral 6-OHDA lesions and GDNF.
    Hoffman AF, van Horne CG, Eken S, Hoffer BJ, Gerhardt GA.
    Exp Neurol; 1997 Sep; 147(1):130-41. PubMed ID: 9294410
    [Abstract] [Full Text] [Related]

  • 42. Reformation of the nigrostriatal pathway by fetal dopaminergic micrografts into the substantia nigra is critically dependent on the age of the host.
    Bentlage C, Nikkhah G, Cunningham MG, Björklund A.
    Exp Neurol; 1999 Sep; 159(1):177-90. PubMed ID: 10486186
    [Abstract] [Full Text] [Related]

  • 43. Rotational behaviour and neurochemical changes in unilateral N-methyl-norsalsolinol and 6-hydroxydopamine lesioned rats.
    Moser A, Siebecker F, Nobbe F, Böhme V.
    Exp Brain Res; 1996 Nov; 112(1):89-95. PubMed ID: 8951410
    [Abstract] [Full Text] [Related]

  • 44. Intrastriatal quinolinic acid injections protect against 6-hydroxydopamine-induced lesions of the dopaminergic nigrostriatal system.
    Venero JL, Romero-Ramos M, Revuelta M, Machado A, Cano J.
    Brain Res; 1995 Feb 20; 672(1-2):153-8. PubMed ID: 7749737
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Acupuncture prevents 6-hydroxydopamine-induced neuronal death in the nigrostriatal dopaminergic system in the rat Parkinson's disease model.
    Park HJ, Lim S, Joo WS, Yin CS, Lee HS, Lee HJ, Seo JC, Leem K, Son YS, Kim YJ, Kim CJ, Kim YS, Chung JH.
    Exp Neurol; 2003 Mar 20; 180(1):93-8. PubMed ID: 12668152
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Behavioral differences in a rotenone-induced hemiparkinsonian rat model developed following intranigral or median forebrain bundle infusion.
    Sindhu KM, Saravanan KS, Mohanakumar KP.
    Brain Res; 2005 Jul 27; 1051(1-2):25-34. PubMed ID: 15992782
    [Abstract] [Full Text] [Related]

  • 49. Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat.
    Kirik D, Rosenblad C, Björklund A.
    Exp Neurol; 1998 Aug 27; 152(2):259-77. PubMed ID: 9710526
    [Abstract] [Full Text] [Related]

  • 50. The antioxidant drink effective microorganism-X (EM-X) pre-treatment attenuates the loss of nigrostriatal dopaminergic neurons in 6-hydroxydopamine-lesion rat model of Parkinson's disease.
    Datla KP, Bennett RD, Zbarsky V, Ke B, Liang YF, Higa T, Bahorun T, Aruoma OI, Dexter DT.
    J Pharm Pharmacol; 2004 May 27; 56(5):649-54. PubMed ID: 15142343
    [Abstract] [Full Text] [Related]

  • 51. Effect of AdGDNF on dopaminergic neurotransmission in the striatum of 6-OHDA-treated rats.
    Smith AD, Kozlowski DA, Bohn MC, Zigmond MJ.
    Exp Neurol; 2005 Jun 27; 193(2):420-6. PubMed ID: 15869944
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Delayed infusion of GDNF promotes recovery of motor function in the partial lesion model of Parkinson's disease.
    Kirik D, Georgievska B, Rosenblad C, Björklund A.
    Eur J Neurosci; 2001 Apr 27; 13(8):1589-99. PubMed ID: 11328352
    [Abstract] [Full Text] [Related]

  • 54. 1,25-Dihydroxyvitamin D3 administration to 6-hydroxydopamine-lesioned rats increases glial cell line-derived neurotrophic factor and partially restores tyrosine hydroxylase expression in substantia nigra and striatum.
    Sanchez B, Relova JL, Gallego R, Ben-Batalla I, Perez-Fernandez R.
    J Neurosci Res; 2009 Feb 15; 87(3):723-32. PubMed ID: 18816795
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Altered melatonin MT1 receptor expression in the ventral midbrain following 6-hydroxydopamine lesions in the rat medial forebrain bundle.
    Kang NH, Carriere CH, Bahna SG, Niles LP.
    Brain Res; 2016 Dec 01; 1652():89-96. PubMed ID: 27693415
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Intranasal insulin protects against substantia nigra dopaminergic neuronal loss and alleviates motor deficits induced by 6-OHDA in rats.
    Pang Y, Lin S, Wright C, Shen J, Carter K, Bhatt A, Fan LW.
    Neuroscience; 2016 Mar 24; 318():157-65. PubMed ID: 26777890
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.